Insights

Recent Investments OrbiMed has recently made significant investments in multiple healthcare companies such as Forte Biosciences, Alentis Therapeutics, and Koya Medical, indicating a strong focus on funding promising ventures in the industry.

Strategic Partnerships The upcoming partnership with TriSalus Life Sciences, along with providing a $50 million credit facility, showcases OrbiMed's commitment to forming strategic alliances and supporting the growth of key players in the healthcare sector.

Global Presence With a team of over 100 professionals located in major cities worldwide like New York, Shanghai, and Mumbai, OrbiMed has a strong global presence, offering ample opportunities for international business collaborations and expansion.

High Revenue Range OrbiMed falls within the revenue range of $10M to $50M, aligning with similar companies like Venrock and Third Rock Ventures, which presents a potential market segment for sales engagement and partnerships within this revenue bracket.

Diverse Financing Solutions Through private equity funds, public equity funds, and royalty/credit funds, OrbiMed provides tailored financing solutions to healthcare companies, indicating a versatile approach that can be leveraged to tailor sales propositions based on specific financial needs.

Similar companies to OrbiMed

OrbiMed Tech Stack

OrbiMed uses 8 technology products and services including Google Analytics, Umbraco, TweenMax, and more. Explore OrbiMed's tech stack below.

Google Analytics
Analytics
Umbraco
Content Management System
TweenMax
Javascript Frameworks
Hammer.js
Javascript Libraries
Flickity
Javascript Libraries
PWA
Miscellaneous
Windows Server
Operating Systems
IIS
Web Servers

Media & News

OrbiMed's Email Address Formats

OrbiMed uses at least 1 format(s):

OrbiMed Email Formats	Example	Percentage
LastF@orbimed.com	DoeJ@orbimed.com	76%
FLast@orbimed.com	JDoe@orbimed.com	17%
First_Last@orbimed.com	John_Doe@orbimed.com	5%
Last@orbimed.com	Doe@orbimed.com	2%

Frequently Asked Questions

Where is OrbiMed's headquarters located?

OrbiMed's main headquarters is located at 601 Lexington Avenue 54th Floor New York, NY 10022 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is OrbiMed's stock symbol?

OrbiMed is a publicly traded company; the company's stock symbol is N/A.

What is OrbiMed's official website and social media links?

OrbiMed's official website is orbimed.com and has social profiles on LinkedIn.

How much revenue does OrbiMed generate?

As of October 2024, OrbiMed's annual revenue reached $35M.

What is OrbiMed's SIC code NAICS code?

OrbiMed's SIC code is 2068 - Salted and Roasted Nuts and Seeds NAICS code is 541320 - Landscape Architectural Services.

How many employees does OrbiMed have currently?

As of October 2024, OrbiMed has approximately 151 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Chief Technology Officer: D. R.Chief Financial Officer: T. B.Chief Compliance Officer: D. C.. Explore OrbiMed's employee directory with LeadIQ.

What industry does OrbiMed belong to?

OrbiMed operates in the Financial Services industry.

What technology does OrbiMed use?

OrbiMed's tech stack includes Google AnalyticsUmbracoTweenMaxHammer.jsFlickityPWAWindows ServerIIS.

What is OrbiMed's email format?

OrbiMed's email format typically follows the pattern of . Find more OrbiMed email formats with LeadIQ.

When was OrbiMed founded?

OrbiMed was founded in 1989.

OrbiMed

Financial ServicesNew York, United States51-200 Employees

OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.